<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font27 { font-size : 27; } .font28 { font-size : 28; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">vaccine </span>
   <span class="font28">mRNA </span>
   <span class="font27">vaccines </span>
   <span class="font21">DNA </span>
   <span class="font21">virus </span>
   <span class="font19">viral </span>
   <span class="font19">responses </span>
   <span class="font18">clinical </span>
   <span class="font17">immune </span>
   <span class="font16">based </span>
   <span class="font16">vector </span>
   <span class="font15">cell </span>
   <span class="font15">cells </span>
   <span class="font15">influenza </span>
   <span class="font15">Ebola </span>
   <span class="font15">RNA </span>
   <span class="font15">vaccination </span>
   <span class="font14">delivery </span>
   <span class="font14">studies </span>
   <span class="font14">antigen </span>
   <span class="font14">human </span>
   <span class="font14">antibody </span>
   <span class="font14">safety </span>
   <span class="font14">development </span>
   <span class="font14">pandemic </span>
   <span class="font14">injection </span>
   <span class="font13">However, </span>
   <span class="font13">encoding </span>
   <span class="font13">expression </span>
   <span class="font13">high </span>
   <span class="font13">production </span>
   <span class="font13">different </span>
   <span class="font13">Vaccine </span>
   <span class="font13">protein </span>
   <span class="font13">vectors </span>
   <span class="font13">demonstrated </span>
   <span class="font13">induce </span>
   <span class="font13">phase </span>
   <span class="font13">study </span>
   <span class="font13">using </span>
   <span class="font13">immunity </span>
   <span class="font13">mice </span>
   <span class="font13">new </span>
   <span class="font12">Phase </span>
   <span class="font12">trials </span>
   <span class="font12">NCT </span>
   <span class="font12">results </span>
   <span class="font12">modified </span>
   <span class="font12">protection </span>
   <span class="font12">subjects </span>
   <span class="font12">use </span>
   <span class="font12">trial </span>
   <span class="font12">response </span>
   <span class="font12">EBOV </span>
   <span class="font12">Zika </span>
   <span class="font12">immunogenicity </span>
   <span class="font12">employed </span>
   <span class="font12">induction </span>
   <span class="font12">non-replicating </span>
   <span class="font12">potential </span>
   <span class="font12">Med. </span>
   <span class="font12">able </span>
   <span class="font12">titers </span>
   <span class="font12">vaccines. </span>
   <span class="font12">{border-style </span>
   <span class="font12">(NCT) </span>
   <span class="font12">(Table </span>
   <span class="font12">administration </span>
   <span class="font12">induced </span>
   <span class="font12">manufacturing </span>
   <span class="font12">neutralizing </span>
   <span class="font12">preclinical </span>
   <span class="font12">target </span>
   <span class="font11">Antigen: </span>
   <span class="font11">antigens </span>
   <span class="font11">challenge </span>
   <span class="font11">doses </span>
   <span class="font11">global </span>
   <span class="font11">protective </span>
   <span class="font11">px;} </span>
   <span class="font11">technologies </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">(/) </span>
   <span class="font11">Mol </span>
   <span class="font11">dose </span>
   <span class="font11">innate </span>
   <span class="font11">outbreak </span>
   <span class="font11">participants </span>
   <span class="font11">vaccines, </span>
   <span class="font11">viruses </span>
   <span class="font11">./j.vaccine... </span>
   <span class="font11">Safety: </span>
   <span class="font11">developed </span>
   <span class="font11">efficacy </span>
   <span class="font11">gene </span>
   <span class="font11">self-amplifying </span>
   <span class="font11">Immunogenicity: </span>
   <span class="font11">antibodies </span>
   <span class="font11">cases </span>
   <span class="font11">context </span>
   <span class="font11">effective </span>
   <span class="font11">encoded </span>
   <span class="font11">established </span>
   <span class="font11">highly </span>
   <span class="font11">potent </span>
   <span class="font11">recombinant </span>
   <span class="font11">Dis. </span>
   <span class="font11">NHPs </span>
   <span class="font11">approaches </span>
   <span class="font11">attenuated </span>
   <span class="font11">derived </span>
   <span class="font11">immunization </span>
   <span class="font11">number </span>
   <span class="font11">profile </span>
   <span class="font11">replication </span>
   <span class="font11">shown </span>
   <span class="font11">single </span>
   <span class="font11">type </span>
   <span class="font11">used </span>
   <span class="font11">DNA, </span>
   <span class="font11">Lancet </span>
   <span class="font11">addition, </span>
   <span class="font11">cellular </span>
   <span class="font11">compared </span>
   <span class="font11">expressing </span>
   <span class="font11">genome </span>
   <span class="font11">i.e., </span>
   <span class="font11">including </span>
   <span class="font11">integration </span>
   <span class="font11">large </span>
   <span class="font11">licensed </span>
   <span class="font11">plasmid </span>
   <span class="font11">responses. </span>
   <span class="font11">risk </span>
   <span class="font11">showed </span>
   <span class="font11">specific </span>
   <span class="font11">tested </span>
   <span class="font11">vitro </span>
   <span class="font11">vivo </span>
   <span class="font11">./S-()- </span>
   <span class="font11">Immunol. </span>
   <span class="font11">Infect </span>
   <span class="font11">Ther. </span>
   <span class="font11">acid </span>
   <span class="font11">adenovirus </span>
   <span class="font11">combination </span>
   <span class="font11">higher </span>
   <span class="font11">humoral </span>
   <span class="font11">immunogenic </span>
   <span class="font11">infection </span>
   <span class="font11">lethal </span>
   <span class="font11">technology </span>
   <span class="font11">testing </span>
   <span class="font11">transgene </span>
   <span class="font11">Acceptable </span>
   <span class="font11">Ebolavirus </span>
   <span class="font11">Vaccines </span>
   <span class="font11">Van </span>
   <span class="font11">ability </span>
   <span class="font11">activation </span>
   <span class="font11">additional </span>
   <span class="font11">adverse </span>
   <span class="font11">associated </span>
   <span class="font11">complex </span>
   <span class="font11">disease </span>
   <span class="font11">genomic </span>
   <span class="font11">healthy </span>
   <span class="font11">increased </span>
   <span class="font11">initiated </span>
   <span class="font11">levels </span>
   <span class="font11">pathogens </span>
   <span class="font11">promising </span>
   <span class="font11">route </span>
   <span class="font11">translation </span>
   <span class="font11">vaccine. </span>
   <span class="font11">Antibody </span>
   <span class="font11">Engl </span>
   <span class="font11">Gene </span>
   <span class="font11">VSV </span>
   <span class="font11">Viral </span>
   <span class="font11">cells, </span>
   <span class="font11">choice </span>
   <span class="font11">delivered </span>
   <span class="font11">discussed </span>
   <span class="font11">events </span>
   <span class="font11">host </span>
   <span class="font11">humans </span>
   <span class="font11">lead </span>
   <span class="font11">low </span>
   <span class="font11">need </span>
   <span class="font11">nucleic </span>
   <span class="font11">pre-existing </span>
   <span class="font11">produced </span>
   <span class="font11">protect </span>
   <span class="font11">proteins </span>
   <span class="font11">provide </span>
   <span class="font11">recent </span>
   <span class="font11">represent </span>
   <span class="font11">responses, </span>
   <span class="font11">site </span>
   <span class="font11">stomatitis </span>
   <span class="font11">support </span>
   <span class="font11">terms </span>
   <span class="font11">vesicular </span>
   <span class="font11">virus, </span>
   <span class="font10">ChAd </span>
   <span class="font10">Hence, </span>
   <span class="font10">Hum </span>
   <span class="font10">Immunother. </span>
   <span class="font10">Nat </span>
   <span class="font10">Safety </span>
   <span class="font10">animal </span>
   <span class="font10">candidate </span>
   <span class="font10">caused </span>
   <span class="font10">commonly </span>
   <span class="font10">containing </span>
   <span class="font10">detectable </span>
   <span class="font10">development. </span>
   <span class="font10">electroporation </span>
   <span class="font10">employing </span>
   <span class="font10">generally </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">humans. </span>
   <span class="font10">increase </span>
   <span class="font10">intradermal </span>
   <span class="font10">intramuscular </span>
   <span class="font10">measles </span>
   <span class="font10">methods </span>
   <span class="font10">months </span>
   <span class="font10">novel </span>
   <span class="font10">primary </span>
   <span class="font10">prophylactic </span>
   <span class="font10">published </span>
   <span class="font10">required </span>
   <span class="font10">strong </span>
   <span class="font10">variety </span>
   <span class="font10">vectors, </span>
   <span class="font10">virus. </span>
   <span class="font10">virus; </span>
   <span class="font10">./.. </span>
   <span class="font10">./NEJMoa </span>
   <span class="font10">Clinical </span>
   <span class="font10">Ebolaviruses </span>
   <span class="font10">Importantly, </span>
   <span class="font10">LNP </span>
   <span class="font10">LNP-formulated </span>
   <span class="font10">Pardi </span>
   <span class="font10">action </span>
   <span class="font10">allow </span>
   <span class="font10">challenges </span>
   <span class="font10">conventional </span>
   <span class="font10">early </span>
   <span class="font10">enhanced </span>
   <span class="font10">exclusively </span>
   <span class="font10">following </span>
   <span class="font10">generation </span>
   <span class="font10">genetic </span>
   <span class="font10">infections </span>
   <span class="font10">infectious </span>
   <span class="font10">leading </span>
   <span class="font10">live </span>
   <span class="font10">naked </span>
   <span class="font10">non-human </span>
   <span class="font10">persistence </span>
   <span class="font10">population </span>
   <span class="font10">presence </span>
   <span class="font10">primates </span>
   <span class="font10">process </span>
   <span class="font10">px; </span>
   <span class="font10">rVSV-ZEBOV </span>
   <span class="font10">relatively </span>
   <span class="font10">remains </span>
   <span class="font10">represents </span>
   <span class="font10">respiratory </span>
   <span class="font10">resulted </span>
   <span class="font10">robust </span>
   <span class="font10">severe </span>
   <span class="font10">synthetic </span>
   <span class="font10">vaccines: </span>
   <span class="font10">week </span>
   <span class="font10">{font-family </span>
   <span class="font10">Biol. </span>
   <span class="font10">DCs </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Given </span>
   <span class="font10">Kariko </span>
   <span class="font10">Muramatsu </span>
   <span class="font10">PFU </span>
   <span class="font10">SUDV </span>
   <span class="font10">Sci </span>
   <span class="font10">Wang </span>
   <span class="font10">advantages </span>
   <span class="font10">approach </span>
   <span class="font10">cap </span>
   <span class="font10">capacity </span>
   <span class="font10">currently </span>
   <span class="font10">days </span>
   <span class="font10">detected </span>
   <span class="font10">distribution </span>
   <span class="font10">double-blind, </span>
   <span class="font10">effects </span>
   <span class="font10">efficiently </span>
   <span class="font10">elicit </span>
   <span class="font10">elicited </span>
   <span class="font10">estimated </span>
   <span class="font10">eukaryotic </span>
   <span class="font10">font-size </span>
   <span class="font10">free </span>
   <span class="font10">generated </span>
   <span class="font10">genes </span>
   <span class="font10">helper </span>
   <span class="font10">inj.dev. </span>
   <span class="font10">likely </span>
   <span class="font10">mRNA, </span>
   <span class="font10">mild </span>
   <span class="font10">order </span>
   <span class="font10">outbreaks </span>
   <span class="font10">particles </span>
   <span class="font10">platform </span>
   <span class="font10">randomised, </span>
   <span class="font10">replicon </span>
   <span class="font10">requires </span>
   <span class="font10">safe </span>
   <span class="font10">sequence </span>
   <span class="font10">small </span>
   <span class="font10">symptoms </span>
   <span class="font10">targeting </span>
   <span class="font10">time </span>
   <span class="font10">transcribed </span>
   <span class="font10">transfer </span>
   <span class="font10">various </span>
   <span class="font10">year </span>
   <span class="font10">(e.g., </span>
   <span class="font10">./s--- </span>
   <span class="font10">APCs, </span>
   <span class="font10">Delivery </span>
   <span class="font10">Ebola, </span>
   <span class="font10">Enama </span>
   <span class="font10">HIV, </span>
   <span class="font10">Induction </span>
   <span class="font10">LNPs </span>
   <span class="font10">NCT; </span>
   <span class="font10">Results </span>
   <span class="font10">Self-amplifying </span>
   <span class="font10">Specific </span>
   <span class="font10">VNTs </span>
   <span class="font10">Vaccin </span>
   <span class="font10">Virol. </span>
   <span class="font10">Weissman </span>
   <span class="font10">ZIKV </span>
   <span class="font10">allowing </span>
   <span class="font10">bacterial </span>
   <span class="font10">completion </span>
   <span class="font10">components </span>
   <span class="font10">concerns </span>
   <span class="font10">conducted </span>
   <span class="font10">constructs </span>
   <span class="font10">date </span>
   <span class="font10">dendritic </span>
   <span class="font10">described </span>
   <span class="font10">disadvantages </span>
   <span class="font10">diseases </span>
   <span class="font10">double; </span>
   <span class="font10">emerging </span>
   <span class="font10">enhance </span>
   <span class="font10">expressed </span>
   <span class="font10">expression. </span>
   <span class="font10">fast </span>
   <span class="font10">fever </span>
   <span class="font10">followed </span>
   <span class="font10">lipid </span>
   <span class="font10">long </span>
   <span class="font10">mammalian </span>
   <span class="font10">mouse </span>
   <span class="font10">needle </span>
   <span class="font10">note, </span>
   <span class="font10">pandemic. </span>
   <span class="font10">pathogen </span>
   <span class="font10">people </span>
   <span class="font10">pigs </span>
   <span class="font10">professional </span>
   <span class="font10">raised </span>
   <span class="font10">rapid </span>
   <span class="font10">remained </span>
   <span class="font10">respectively </span>
   <span class="font10">respectively. </span>
   <span class="font10">restricted </span>
   <span class="font10">resulting </span>
   <span class="font10">role </span>
   <span class="font10">routes </span>
   <span class="font10">species </span>
   <span class="font10">started </span>
   <span class="font10">supporting </span>
   <span class="font10">threat </span>
   <span class="font10">threats. </span>
   <span class="font10">transcription </span>
   <span class="font10">transfected </span>
   <span class="font10">vaccine, </span>
   <span class="font10">vaccinia </span>
   <span class="font10">versatile </span>
   <span class="font10">yielded </span>
   <span class="font10">(VRC) </span>
   <span class="font10">APCs </span>
   <span class="font10">Acad </span>
   <span class="font10">Adenovirus </span>
   <span class="font10">Aug </span>
   <span class="font10">Clin </span>
   <span class="font10">Curr </span>
   <span class="font10">EBOLA </span>
   <span class="font10">Expert </span>
   <span class="font10">Fotin-Mleczek </span>
   <span class="font10">GPs </span>
   <span class="font10">Geisbert </span>
   <span class="font10">Johnson </span>
   <span class="font10">MVA </span>
   <span class="font10">Marburg </span>
   <span class="font10">Methods </span>
   <span class="font10">Natl </span>
   <span class="font10">Nature </span>
   <span class="font10">Petsch </span>
   <span class="font10">Proc </span>
   <span class="font10">Rev </span>
   <span class="font10">SARS </span>
   <span class="font10">Sullivan </span>
   <span class="font10">T-cell </span>
   <span class="font10">Thess </span>
   <span class="font10">USA. </span>
   <span class="font10">VSV, </span>
   <span class="font10">adaptive </span>
   <span class="font10">adenoviral </span>
   <span class="font10">administered </span>
   <span class="font10">adults </span>
   <span class="font10">agents </span>
   <span class="font10">and, </span>
   <span class="font10">antigen. </span>
   <span class="font10">arthritis </span>
   <span class="font10">available </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">case </span>
   <span class="font10">cells. </span>
   <span class="font10">certain </span>
   <span class="font10">chimpanzee </span>
   <span class="font10">clusters </span>
   <span class="font10">contains </span>
   <span class="font10">cost </span>
   <span class="font10">crisis </span>
   <span class="font10">demonstrating </span>
   <span class="font10">direct </span>
   <span class="font10">efforts </span>
   <span class="font10">elicits </span>
   <span class="font10">emergence </span>
   <span class="font10">extremely </span>
   <span class="font10">facilities </span>
   <span class="font10">ferrets </span>
   <span class="font10">fully </span>
   <span class="font10">future </span>
   <span class="font10">group </span>
   <span class="font10">hemagglutinin </span>
   <span class="font10">homologous </span>
   <span class="font10">important </span>
   <span class="font10">induces </span>
   <span class="font10">insertion </span>
   <span class="font10">mRNA-based </span>
   <span class="font10">memory </span>
   <span class="font10">method </span>
   <span class="font10">million </span>
   <span class="font10">model </span>
   <span class="font10">models </span>
   <span class="font10">nucleoside-modified </span>
   <span class="font10">occurrence </span>
   <span class="font10">offers </span>
   <span class="font10">ongoing </span>
   <span class="font10">pathogens. </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">platforms </span>
   <span class="font10">presentation </span>
   <span class="font10">prevent </span>
   <span class="font10">process. </span>
   <span class="font10">properties </span>
   <span class="font10">rabies </span>
   <span class="font10">reduced </span>
   <span class="font10">regions </span>
   <span class="font10">regulatory </span>
   <span class="font10">rely </span>
   <span class="font10">report </span>
   <span class="font10">require </span>
   <span class="font10">respective </span>
   <span class="font10">safety, </span>
   <span class="font10">settings </span>
   <span class="font10">seven </span>
   <span class="font10">solid; </span>
   <span class="font10">stable </span>
   <span class="font10">start </span>
   <span class="font10">strain </span>
   <span class="font10">studies, </span>
   <span class="font10">successfully </span>
   <span class="font10">surface </span>
   <span class="font10">systems </span>
   <span class="font10">tail </span>
   <span class="font10">targets </span>
   <span class="font10">template </span>
   <span class="font10">therapy </span>
   <span class="font10">tissue </span>
   <span class="font10">tolerability </span>
   <span class="font10">transfection </span>
   <span class="font10">translational </span>
   <span class="font10">uptake </span>
   <span class="font10">vaccination. </span>
   <span class="font10">weeks </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(HA </span>
   <span class="font10">(ID) </span>
   <span class="font10">(IM) </span>
   <span class="font10">./journal.pone. </span>
   <span class="font10">./mt.. </span>
   <span class="font10">./pnas. </span>
   <span class="font10">Aberle </span>
   <span class="font10">Adenoviral </span>
   <span class="font10">Africa </span>
   <span class="font10">Baumhof </span>
   <span class="font10">ChAd, </span>
   <span class="font10">Dec </span>
   <span class="font10">Despite </span>
   <span class="font10">GP) </span>
   <span class="font10">GP, </span>
   <span class="font10">Giovani </span>
   <span class="font10">H-specific </span>
   <span class="font10">HIV </span>
   <span class="font10">HN, </span>
   <span class="font10">HPLC </span>
   <span class="font10">I/II </span>
   <span class="font10">IM, </span>
   <span class="font10">INFLUENZA </span>
   <span class="font10">Immunol </span>
   <span class="font10">Immunology </span>
   <span class="font10">Indeed, </span>
   <span class="font10">LNP-formulated, </span>
   <span class="font10">Med </span>
   <span class="font10">NCT) </span>
   <span class="font10">Nabel </span>
   <span class="font10">Nucleic </span>
   <span class="font10">Oct </span>
   <span class="font10">Opin </span>
   <span class="font10">Osterhaus </span>
   <span class="font10">RNA, </span>
   <span class="font10">RNAs </span>
   <span class="font10">Sept </span>
   <span class="font10">TLR </span>
   <span class="font10">Table </span>
   <span class="font10">Ther </span>
   <span class="font10">VRPs </span>
   <span class="font10">West </span>
   <span class="font10">Yang </span>
   <span class="font10">ZIKA </span>
   <span class="font10">Zhu </span>
   <span class="font10">activity </span>
   <span class="font10">acute </span>
   <span class="font10">addition </span>
   <span class="font10">adults: </span>
   <span class="font10">allows </span>
   <span class="font10">antibiotic </span>
   <span class="font10">applications </span>
   <span class="font10">assessed </span>
   <span class="font10">bold </span>
   <span class="font10">boosted </span>
   <span class="font10">boosting </span>
   <span class="font10">broad </span>
   <span class="font10">candidates </span>
   <span class="font10">cationic </span>
   <span class="font10">co-stimulatory </span>
   <span class="font10">complete </span>
   <span class="font10">confirmed </span>
   <span class="font10">considerations </span>
   <span class="font10">considered </span>
   <span class="font10">correlate </span>
   <span class="font10">courier; </span>
   <span class="font10">cytoplasm </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">data </span>
   <span class="font10">deaths </span>
   <span class="font10">demonstrate </span>
   <span class="font10">design </span>
   <span class="font10">develop </span>
   <span class="font10">developing </span>
   <span class="font10">devices </span>
   <span class="font10">directly </span>
   <span class="font10">diseases. </span>
   <span class="font10">does </span>
   <span class="font10">effect </span>
   <span class="font10">efficient </span>
   <span class="font10">em; </span>
   <span class="font10">encephalitis </span>
   <span class="font10">endosomal </span>
   <span class="font10">especially </span>
   <span class="font10">essential </span>
   <span class="font10">established, </span>
   <span class="font10">events. </span>
   <span class="font10">experiments </span>
   <span class="font10">factor </span>
   <span class="font10">factors </span>
   <span class="font10">far </span>
   <span class="font10">focus </span>
   <span class="font10">function </span>
   <span class="font10">functional </span>
   <span class="font10">glycoproteins </span>
   <span class="font10">growth </span>
   <span class="font10">gun </span>
   <span class="font10">health </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">infect </span>
   <span class="font10">infected </span>
   <span class="font10">information </span>
   <span class="font10">known </span>
   <span class="font10">lack </span>
   <span class="font10">led </span>
   <span class="font10">limited </span>
   <span class="font10">lines </span>
   <span class="font10">local </span>
   <span class="font10">luciferase </span>
   <span class="font10">major </span>
   <span class="font10">material </span>
   <span class="font10">mechanism </span>
   <span class="font10">mice, </span>
   <span class="font10">minimal </span>
   <span class="font10">moderate </span>
   <span class="font10">monovalent; </span>
   <span class="font10">multitude </span>
   <span class="font10">muscle </span>
   <span class="font10">myocytes </span>
   <span class="font10">nanoparticles </span>
   <span class="font10">natural </span>
   <span class="font10">negative </span>
   <span class="font10">nucleoprotein </span>
   <span class="font10">nucleotides </span>
   <span class="font10">nucleotides; </span>
   <span class="font10">open-label, </span>
   <span class="font10">optimized </span>
   <span class="font10">oral </span>
   <span class="font10">organisms </span>
   <span class="font10">overcome </span>
   <span class="font10">past </span>
   <span class="font10">place </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">plasma </span>
   <span class="font10">poly(A) </span>
   <span class="font10">possible </span>
   <span class="font10">post </span>
   <span class="font10">prM-E; </span>
   <span class="font10">prevalence </span>
   <span class="font10">previously </span>
   <span class="font10">priming </span>
   <span class="font10">processes </span>
   <span class="font10">production. </span>
   <span class="font10">protects </span>
   <span class="font10">pt;} </span>
   <span class="font10">purification </span>
   <span class="font10">ranging </span>
   <span class="font10">recombination </span>
   <span class="font10">related </span>
   <span class="font10">removed </span>
   <span class="font10">research </span>
   <span class="font10">seasonal </span>
   <span class="font10">settings. </span>
   <span class="font10">significantly </span>
   <span class="font10">similar </span>
   <span class="font10">situations. </span>
   <span class="font10">spread </span>
   <span class="font10">stability </span>
   <span class="font10">strains </span>
   <span class="font10">syncytial </span>
   <span class="font10">syndrome </span>
   <span class="font10">systemic </span>
   <span class="font10">table </span>
   <span class="font10">technologies. </span>
   <span class="font10">tolerated </span>
   <span class="font10">total </span>
   <span class="font10">translated </span>
   <span class="font10">transmembrane </span>
   <span class="font10">trivalent </span>
   <span class="font10">unmodified </span>
   <span class="font10">vaccinated </span>
   <span class="font10">vaccination, </span>
   <span class="font10">vaccine: </span>
   <span class="font10">vector-based </span>
   <span class="font10">years </span>
   <span class="font10">yields </span>
  </p>
 </body>
</html>
